Top Pbms 2025 Countries. The evolution of PBMs over the past 2 decades The recent announcement by the FDA that tirzepatide is no longer on the drug shortage list has triggered heightened oversight of compounding practices The market for PBM services is highly concentrated, with the top three firms (CVS Health/Caremark, Cigna (Evernorth/Express Scripts, and UnitedHealth (OptumRx) controlling an estimated nearly 80% of the market.
FTC and Congress Put PBMs on Notice AAF from www.americanactionforum.org
Convenience store chain 7-Eleven and Purdue University will be moving to AffirmedRx in 2025 The Pharmacy Benefit Management Market is expected to reach USD 622.64 billion in 2025 and grow at a CAGR of 5.64% to reach USD 819.18 billion by 2030
FTC and Congress Put PBMs on Notice AAF
Most recently, in December 2024, the Patients Before Monopolies (PBM) Act was introduced in the Senate Four major trends stand out as pivotal in 2025 and beyond: the movement toward transparent PBM models. The pharmacy benefits management (PBM) landscape is changing as employers, insurers, and policymakers push for more transparency, cost-effectiveness, and better overall outcomes
Real GDP growth for BRICS and the world. 2025 projection. Source IMF. The recent announcement by the FDA that tirzepatide is no longer on the drug shortage list has triggered heightened oversight of compounding practices Fresh data on plan sponsors' perspectives on their PBM partners; Key takeaways from PBMs' 2025 commercial formularies;
Our 2025 Roadmap Phillip Morris International. The pharmacy benefits management (PBM) landscape is changing as employers, insurers, and policymakers push for more transparency, cost-effectiveness, and better overall outcomes The 2024-2025 PBM Review (210 pages) offers comprehensive intelligence on nearly 70 PBM companies